Riskpilot← Back to searchSign inGet full accessBT Medicals AB
ABActiveOrg 5594051970Scheelevägen 30Activities of agents involved in the wholesale of other particular products · NACE 4618Est. 20223 employees
Revenue 2024
SEK 4,2M
+55% vs 2023
EBITDA margin
-53.7%
-2% vs 2023
Equity ratio
10.9%
Financial strength
Net profit 2024
SEK -2,3M
-2% vs 2023
| Revenue | SEK 4,2M | +55% |
| EBITDA | SEK -2,3M | -2% |
| Net profit | SEK -2,3M | -2% |
| Total assets | SEK 2,6M | +320% |
| Equity | SEK 280K | +4% |
| Employees | 3 | — |
Legal name
BT Medicals AB
Org number
5594051970
Legal form
Aktiebolag
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
9 november 2022
Share capital
SEK 25 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva försäljning, kunskap och utveckling av allografts (vävnadsprodukter) och medicinsk utrustning som används till ortopediska operationer och därmed förenlig verksamhet.
Address
Scheelevägen 30
Email
pm@btmedicals.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 2 728 | 4 228 |
| Staff expenses | −2 150 | −2 633 |
| EBITDA | −2 221 | −2 269 |
| Depreciation & amort. | −25 | −22 |
| EBIT | −2 246 | −2 291 |
| Net financials | −4 | −3 |
| Profit before tax | −2 249 | −2 293 |
| Tax | — | — |
| Net profit | −2 249 | −2 293 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 613 | 2 575 |
| Equity | 269 | 280 |
| Long-term debt | — | — |
| Short-term debt | 344 | 2 295 |
| Total debt | 344 | 2 295 |
EBITDA margin
-53.7%
This company
15.8%
Market median
-440% vs market
20232024
Equity ratio
10.9%
This company
38.2%
Market median
-71% vs market
20232024
Return on equity
-819.8%
This company
18.4%
Market median
-4555% vs market
20232024
Net profit margin
-54.2%
This company
8.1%
Market median
-769% vs market
20232024
Asset turnover
1.64×
This company
1.12×
Market median
+46% vs market
20232024
Debt / equity
8.20×
This company
0.62×
Market median
-1223% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PK Chief Executive Officer | Chief Executive Officer | 2026 |
| Former (1) | ||
JB Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BT Medicals AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pär Kristian Magnusson | Chief Executive Officer | 0 companies |
| Jørgen Bertram | Chief Executive Officer | 0 companies |
| Eric Adrian Torres | Board of Directors | 0 companies |
| Ulf Stig Mikael Palm Andersson | Chairman | 0 companies |
| Toni Matthias Freytag | Board of Directors | 0 companies |
| Andreas Kogler | Board of Directors | 0 companies |